FIELD: medicine.
SUBSTANCE: invention relates to Legg-Calve-Perthes disease (LCPD) model, which can be used to test various treatments and osteonecrosis prevention agents. The simulation method involves introduction of 0.1% epinephrine in the periarticular tissues of the hip joint at a dose of 0.5 ml daily for 1 month. From the 15th day of preparation administration, tractions are applied additionally to the hip joint, including full flexion with limb subsequent extension, daily, 10 times of 3 repetitions, for 15 days.
EFFECT: method increases the simulation reliability due to the effect on different parts of disease pathogenesis with decreased invasiveness and risk of animals death.
1 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SURGICAL MANAGEMENT OF PERTHES DISEASE | 2014 |
|
RU2565334C1 |
METHOD FOR MODELING ASEPTIC NECROSIS OF THE FEMORAL HEAD IN LABORATORY RATS | 2021 |
|
RU2773606C1 |
METHOD OF PREOPERATIVE COMPUTER INVERSION MODELING OF THE ACETABULAR COMPONENT IN DYSPLASTIC COXARTHROSIS | 2019 |
|
RU2700472C1 |
METHOD FOR CREATING SEGMENTAL OSTEONECROSIS MODEL OF CONDYLE FORMING ANIMAL KNEE JOINT | 2004 |
|
RU2269824C2 |
METHOD FOR MODELLING ASEPTIC NECROSIS OF HEAD OF THE FEMUR | 1990 |
|
RU2009547C1 |
METHOD FOR TREATMENT OF EARLY STAGES OF OSTEONECROSIS OF FEMORAL HEAD | 2022 |
|
RU2792548C1 |
METHOD FOR TREATING ASEPTIC NECROSIS OF CAPUT FEMORIS AND PERTHES DISEASE | 2005 |
|
RU2286735C1 |
METHOD FOR TREATMENT OF ASEPTIC NECROSIS OF THE FEMORAL HEAD AT STAGE 0 TO 1 OF ASEPTIC NECROSIS ACCORDING TO ARCO | 2020 |
|
RU2754512C1 |
METHOD OF MODELLING OF ASEPTIC FEMUR HEAD NECROSIS ON LABORATORY ANIMALS | 2007 |
|
RU2354313C1 |
METHOD FOR MODELING FEMUR AND PELVIC BONE ANOMALY | 2003 |
|
RU2279144C2 |
Authors
Dates
2017-07-28—Published
2016-10-11—Filed